Oragenics Inc
OGEN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001174940
No open-market purchases or sales by Oragenics Inc insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $39.2K in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Oragenics Inc changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 24 | 22 | −2 |
| Shares | 235.2K | 273.4K | +38.2K (+16.3%) |
| Value | $86.0K | $57.2K | −$28.8K (−33.4%) |
New holders (3)
Institutions that held Oragenics Inc at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mutual Advisors, LLC | 16,000 | $3.15K | 0.00% |
| Hexagon Capital Partners LLC | 275 | $58 | 0.00% |
| Farther Finance Advisors, LLC | 1 | $0 | 0.00% |
Sold out (5)
Institutions that held Oragenics Inc at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| HRT Financial LP | 18,640 | $6.00K |
| Warberg Asset Management LLC | 10,001 | $3.69K |
| Wolff Wiese Magana LLC | 67 | $25 |
| Advisor Group Holdings, Inc. | 6 | $2 |
| FMR LLC | 1 | $0 |